273245
Clinical development Bardoxolone methyl was previously being investigated by Reata Pharmaceuticals , Inc. in partnership with Abbott Laboratories and Kyowa Hakko Kirin , as an experimental therapy for advanced chronic kidney disease ( CKD ) in type 2 diabetes mellitus patients .
 Abbott Laboratories, Kyowa Hakko Kirin
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: location, person, organization 
Text: {0} 
Answer:
 Abbott Laboratories, Kyowa Hakko Kirin